Explore AstraZeneca PLC's August 2025 Form 6-K report detailing The Capital Group's voting rights changes, impacting governance. Key insights on acquisitions and shareholder dynamics.
Explore Arm Holdings PLC's Form 6-K report detailing significant updates for August 11, 2025. Key insights on financials and events impacting Q2 2026.
Explore GLOBALFOUNDRIES Inc.'s Form 6-K filing for August 2025, featuring key financial updates, signed by CFO John Hollister, and an attached press release for detailed insights.
Explore ARM Holdings PLC's Form 6-K for Q2 2025, detailing significant financial updates in XBRL format. Stay informed about their latest reporting period and performance insights.
Explore the June 2025 Form 6-K report for GLOBALFOUNDRIES Inc., detailing governance, annual meeting, and SEC compliance.
Explore ARM Holdings PLC's 6-K report detailing significant Q1 2025 events. Key insights for investors on performance and future implications.
On February 24, 2025, Telix Pharmaceuticals Limited filed a Form 6-K announcing the change of its reporting currency to USD. Insights on market impact and compliance included.
Antelope Enterprise Holdings Ltd. amends Form 6-K to clarify auditor changes and correct filing date. Key updates on ARK PRO CPA dismissal and AssentSure PAC engagement.
Explore Galapagos NV's February 2025 Form 6-K, detailing financial filings, recent press releases, and compliance with SEC regulations.
Explore Agora, Inc.'s February 2025 Form 6-K report highlighting CFO Jingbo Wang's insights, filing details, and important exhibits.
Explore Radiopharm Theranostics Limited's Feb 2025 Form 6-K, detailing director interests & securities changes. Key updates for investors.
Explore Bitdeer Technologies Group's February 2025 Form 6-K filing, featuring key financial results and insights for investors. Signed by CEO Jihan Wu.